TBX5-AS1, an enhancer RNA, is a potential novel prognostic biomarker for lung adenocarcinoma.

Cheng, Lin; Han, Tong; Chen, Bolin; Nie, Kechao; Peng, Weijun

Cheng, Lin; Han, Tong; Chen, Bolin; Nie, Kechao; Peng, Weijun.

Afiliação

Cheng L; Department of Integrated Traditional Chinese & Western Medicine, The Second Xiangya Hospital, Central South University, No.139 Middle Renmin Road, Changsha, Hunan, 410011, People's Republic of China.
Han T; Department of General Surgery, The Second Xiangya Hospital, Central South University, Changsha, 410011, Hunan, China.
Chen B; Department of Thoracic Medical Oncology, Hunan Cancer Hospital/the affiliated Cancer Hospital of Xiangya school of Medicine, Central South University, Changsha, 410013, Hunan, China.
Nie K; Department of Integrated Traditional Chinese & Western Medicine, The Second Xiangya Hospital, Central South University, No.139 Middle Renmin Road, Changsha, Hunan, 410011, People's Republic of China.
Peng W; Department of Endocrinology, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510405, Guangdong, China.

BMC Cancer ; 21(1): 794, 2021 Jul 09.

Article em En | MEDLINE | ID: mdl-34238250

Assuntos

Adenocarcinoma de Pulmão/genética; Biomarcadores Tumorais/metabolismo; Neoplasias Pulmonares/genética; Proteínas com Domínio T/metabolismo; Adenocarcinoma de Pulmão/patologia; Humanos; Neoplasias Pulmonares/patologia; Prognóstico

Palavras-chave

Enhancer RNA; LUAD; Prognostic biomarker; TBX5; TBX5-AS1

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biomarcadores Tumorais / Proteínas com Domínio T / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: BMC Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google